Cerus extends Fresenius supply agreement for INTERCEPT disposables through 2031

CERUS CORP

Second Amended and Restated Supply and Manufacturing Agreement signed May 2, 2022, term until Dec 31, 2031.
Fresenius obligated to manufacture finished platelet and plasma disposable kits; Cerus obligated to purchase.
Cerus may source from third parties for supply qualifications or local/regional manufacturing needs.
Fresenius will expand production to three facilities following qualification and licensure.
Pricing based on volume with annual adjustment tied to a price index; standard termination rights apply.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.